Choose Your News
Loading...
Thumbnail
Sarepta Therapeutics Inc. is best known for the storm of controversy around its Duchenne muscular dystrophy therapy Exondys 51, which was approved in 2016, but... [Read More]
The following slide deck was published by Sarepta Therapeutics, Inc. in conjunction with this event. [Read More]
Thumbnail
CAMBRIDGE, Mass., Dec. 29, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development. [Read More]
Thumbnail
CAMBRIDGE, Mass., Dec. 27, 2017-- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company focused on the discovery and development. [Read More]
Preview